Edition:
United States

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

39.95USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$39.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,365
52-wk High
$58.36
52-wk Low
$38.70

Chart for

About

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)

Overall

Beta: 1.58
Market Cap(Mil.): $287.21
Shares Outstanding(Mil.): 7.19
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-Biospecifics Technologies reports Q3 eps of $0.37

* Biospecifics Technologies Corp reports Q3 2017 financial results

Nov 10 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $133.15 +1.92
Novartis AG (NOVN.S) CHF79.96 +0.28
Pfizer Inc. (PFE.N) $36.26 +0.55
Roche Holding Ltd. (ROG.S) CHF223.50 +0.35
Roche Holding Ltd. (RO.S) CHF226.60 +0.60
Merck & Co., Inc. (MRK.N) $56.29 +0.30
Bayer AG (BAYGn.DE) €98.15 +0.37
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €64.37 +0.07
GlaxoSmithKline plc (GSK.L) 1,313.60 +5.00

Earnings vs. Estimates